Determinants of prehospital coronary heart disease death by Amann, Ute et al.
1
Vol.:(0123456789)
Scientific Reports |        (2021) 11:17134  | https://doi.org/10.1038/s41598-021-96575-2
www.nature.com/scientificreports
Determinants of prehospital 
coronary heart disease death
Ute Amann1*, Margit Heier2,3, Christian Thilo4, Jakob Linseisen1,5,6 & Christa Meisinger1,5
Limited data on prehospital and early in-hospital coronary heart disease (CHD) deaths is available. 
Aims of this study were to provide a comprehensive description on CHD cases and to analyse 
determinants of prehospital death. From a population-based myocardial infarction (MI) registry 
in Augsburg, Germany we included 12,572 CHD cases aged 25–74 years between 2003–2017 and 
4754 CHD cases aged 75–84 years between 2009–2017. Multivariable logistic regression models 
were conducted to identify patient characteristics associated with prehospital death compared to 
28-day survival. In patients aged 25–74 years, 1713 (13.6%) died prehospital, 941 (7.5%) died within 
the first 24 h in-hospital and 560 (4.5%) died within the 2nd and 28th day after the acute event; in 
patients aged 75–84 years the numbers were 1263 (26.6%), 749 (15.8%) and 329 (6.9%), respectively. 
In both age groups increasing age, actual smoking or nicotine abuse, previous MI, angina pectoris 
and previous stroke were more likely and hypertension was less likely in cases, who died prehospital 
compared to 28-day survivors. For example, in the 25–74 years old we revealed an adjusted odds 
ratio (OR) of 4.53 (95% CI 3.84–5.34) for angina pectoris and an OR of 0.69 (95% CI 0.57–0.85) for 
hypertension. In cases aged 25–74 years, an association of living alone (OR 1.26, 95% CI 1.06–1.49) 
and diabetes (OR 1.20, 95% CI 1.03–1.41) with prehospital death was found. Whereas in cases aged 
75–84 years, chronic obstructive pulmonary disease (OR 2.20, 95%CI 1.69–0.2.85) was associated 
with prehospital death. In summary, we observed high prehospital and early in-hospital case fatality. 
Besides classical cardiac risk factors, the impact of living alone on prehospital death was more 
important in patients aged 25–74 years than in older patients.
Over the last decades, morbidity and mortality in acute myocardial infarction (MI) has declined in men and 
women of almost all European populations  analysed1. The World Health Organization (WHO) multinational 
MONICA (MONItoring Trends and Determinants in CArdiovascular disease) project found that over the 
10 years studied from the early 1980s, the fall in coronary heart disease (CHD) mortality rates in the popula-
tion aged 35–64 years was two thirds determined by decline in coronary-event rates and one third by decline in 
case  fatality2. Even among persons above 74 years the CHD event rates and the 28-day case fatality, defined as 
‘as number of deaths within 28 days (mortality) divided by fatal plus non-fatal coronary events (morbidity) by 
100’, has decreased in western countries such as  Finland3 and  Germany4. Besides this success, recent data of the 
population-based MI registry in Germany showed a prehospital case fatality of 27.8% in 25 to 84 years old men 
and 36.5% in women of the same age-range in 2016/2018. In addition, case fatality during the first 24 h after 
hospitalization was 11.6% in men and 12.9% in  women4. Similarly, a high percentage of 28.9% with an out-of-
hospital death due to CHD were reported from Sweden in a nationwide study during 1991 to 2006. The authors 
found that the relative contribution of out-of-hospital death to overall case fatality increased with time, especially 
among younger persons aged 35–54 years with 15.7% of all events dying outside the hospital and 1.9% dying in 
hospital within 28 days after hospital  admission5.
Several causes were discussed to be responsible for an early death after an acute coronary event, ranging 
from age, comorbidities and cardiovascular (CV) risk factors of the individual person, to late diagnosis and 
late administration of reperfusion therapy due to delayed perception of typical MI symptoms and late call for 
emergency medical services or a delayed prehospital time in  general6. In addition, some of the early death events 
are presumable sudden coronary deaths resulting from abrupt loss of heart function within minutes after the 
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onset of symptoms in person with known or unknown CV  disease6,7. As systematic assessment of prehospital 
case fatality in patients with CHD is complicated, less is known about the circumstances and characteristics of 
these  patients8. To study determinants and correlates of early cardiac death due to a possible MI on a population 
level, epidemiological registries or surveys with additional information from death certificates and last treating 
physicians may provide useful information. In contrast to epidemiological MI registries, clinical or physician 
self-reported MI registries have the disadvantage of not collecting prehospital deaths and may under-register early 
in-hospital  deaths8. In addition to a nearly complete case enrolment over long periods, epidemiological studies 
also provide the advantage to collect further information on patient characteristics and risk factors assessed with 
standardized questionnaires and  procedures9. In case of national diagnosis and death registries, data linkage offers 
a valuable source for out-of-hospital CHD cases and their CV risk  factors5,10. Several registry studies analysed 
trends in coronary event rates and CHD  mortality1–3,5, but only few studies investigated patients’ characteristics 
associated with of out-of-hospital  deaths5,10–12.
Aims of this study were firstly, to provide information on sociodemographic characteristics, medical history 
and CV risk factors among persons registered in a population-based MI registry from 2003 to 2017 by survival 
status with a special focus on prehospital deaths and early in-hospital deaths. Secondly, to analyse potential 
determinants associated with prehospital death compared to 28-day survival after the acute coronary event.
Methods
Study design and data source. The present observational study is based on data from the epidemiologi-
cal MI registry in Augsburg, Germany, which was established in 1984 as part of the WHO MONICA Project. 
After the termination of MONICA in 1995, the Augsburg MI registry has been continued as part of KORA 
(Cooperative Health Research in the Region of Augsburg). Since 1984, population-based CHD event monitoring 
and acute coronary care recording is continuously done in the 25–74-year old population of the city of Augs-
burg and two surrounding counties (about 680,000 inhabitants). Besides the region’s major hospital, University 
Hospital of Augsburg, further seven hospitals participated in the MI registry. From 2009 onwards, the KORA MI 
registry was extended up to the 85-year old inhabitants of the study region. According to the MONICA  manual9 
registered events are classified depending on the length of survival into two main groups: (A) fatal cases and (B) 
non-fatal cases, and further into the following four subgroups: (A1) prehospital deaths, (A2) deaths within 24 h 
after hospitalization, (B1) cases surviving at least 24 h after hospitalization, but dying within 28 days after the 
acute event and (B2) cases surviving at least 28 days (28-day survivors). The methods of fatal and non-fatal case 
identification, diagnostic classification of events and data quality control in the KORA MI registry have been 
described in detail  elsewhere13,14. Briefly, fatal CHD (ICD-9: 410–414) were identified using anonymised death 
certificates from the local health departments within the study region. Up to December 31, 2000, hospitalized 
cases were registered according to the diagnostic criteria of the WHO MONICA  protocol9 using symptoms, elec-
trocardiogram, enzyme such as creatine phosphokinase and necropsy  evidence14. Since 2001, all patients with 
acute MI diagnosed according to the European Society of Cardiology and the American College of Cardiology 
have been  registered14,15. Diagnostic evidence is used to classify the registered events as definite (with necropsy 
evidence) acute MI, possible acute MI, ischemic arrest, fatal cases with insufficient data, and non-events (‘false 
positives’)13. Validation of all CHD cases is performed by the physicians of the registry. For reasons of compa-
rability, the epidemiologic MONICA algorithm has been applied in this study for the fatal CHD and non-fatal 
acute MI diagnosis for the whole study period. The documented troponin values that have been collected since 
2001 were not considered for the epidemiologic acute MI diagnosis.
Data collection. The procedure of data collection in the KORA MI registry depends on the two main reg-
istered groups as described above. For prehospital deaths and deaths within 24  h after hospitalization, data 
gathering was performed anonymously with the support of the local health departments and the participating 
hospitals in the study region through screening of death certificates in addition to a written standardized ques-
tionnaire, routinely sent by the local health department to the last treating physician. Non-fatal cases were inter-
viewed shortly after intensive care and a review of medical charts were performed by trained study nurses using 
a standardized questionnaire. Both questionnaires (for fatal and non-fatal cases) collected sociodemographic 
characteristics, CV risk factors (e.g., hypertension, dyslipidaemia, diabetes mellitus, smoking or nicotine abuse), 
medical history of previous MI, stroke, chronic obstructive pulmonary disease (COPD), cancer, and informa-
tion on the acute event reported either by patient, hospital chart or last treating physician. If the information 
on medical history from patient-report and medical chart differed, the chart information was used. Due to the 
different procedure of data collection in fatal and non-fatal cases, some patient characteristics such as obesity 
(reported by last treating physicians in fatal cases vs. defined according to the body weight and height measured 
during hospitalization) and smoking (nicotine abuse reported by last treating physicians vs. actual, former or 
never smoking reported by patients) were not identically or were totally missing such as information on cancer, 
and up to 2008 on COPD in non-fatal cases. Hospitalized patients who refused to participate were registered 
with information only on sex, age and date of the event.
Ethics approval and consent to participate. Data collection of the KORA MI registry has been 
approved by the ethics committee of the Bavarian Medical Association (Bayerische Landesärztekammer) and 
the study was performed in accordance with the Declaration of Helsinki. All study participants with a non-fatal 
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Study population. Out of the 21,862 persons aged 25–84 years who were consecutively enrolled in the 
KORA MI registry between January 1, 2003 (2009 for the 75–84-year old participants), and December, 31, 2017, 
we excluded 171 hospitalized persons who refused to participate and 4365 cases without diagnostic evidence 
(e.g., unclassifiable coronary death cases, registered non-events and non-fatal cases with no validated MI diag-
nosis). Thus, the study population of the present study covered 17,326 cases (12,572 cases aged 25–74 years 
between 2003 and 2017 and 4754 cases aged 75–84 years between 2009 and 2017) (Fig. 1).
Statistical analysis and patient groups analysed. All analyses were performed separately for the 
25–74-year old participants for the time period 2003–2017 and for the 75–84-year old participants from 2009 
to 2017. To describe the characteristics of the cases categorical variables were expressed as absolute numbers 
and percentages (%) and continuous variables as median with interquartile range (25th and 75th percentiles). 
To analyse potential determinants associated with prehospital death (yes/no) multivariable logistic models were 
performed. As comparison group, the 28-day-survivors were used. The following variables were analysed by 
conducting a complete-case analysis: sex, age (continuous), living alone, previous MI, medical history of stroke, 
angina pectoris, hypertension, diabetes mellitus, dyslipidaemia, actual smoking/nicotine abuse (non-fatal/fatal 
cases), COPD (cases aged 75–84 years) and obesity reported by last treating physician (fatal cases) or defined as 
body mass index >  = 30 kg/m2 (non-fatal cases). These patients’ characteristics were cross tabulated with survival 
status (prehospital death vs. 28-day survival) using  Chi2-test for categorical variables and the Kruskal–Wallis 
test (Wilcoxon Analysis) for continuous variables. As criterion for entry into the models, the explanatory vari-
ables—except for sex and age—had to meet the 0.2 significance level in the bivariate analysis. The final multivari-
able models included only factors which significantly (p < 0.05) contributed to the specific model using forward 
selection technique. Due to missing values, we excluded 854 prehospital death cases and 940 cases of 28-day 
survivors of the 25–74-year old participants in the final model, and n = 359 prehospital death cases and 409 cases 
of 28-day survivors of the 75–84-year old participants, respectively. As sub-analyses, the regression models were 
recalculated using all short-term fatal cases (prehospital deaths and deaths within the first 24 h after hospitaliza-
tion) compared to 28-day survivors.
All analyses were performed using SAS version 9.4 (SAS Institute Inc., Cary, North Carolina).
Results
Sample characteristics by survival status. From the 17,326 CHD cases included in this study, 
12,660 were non-fatal and 4666 fatal cases. The distribution between non-fatal and fatal cases was 79:21 in the 
25–74 years old during the time period 2003 and 2017, and 58:42 in the 75–84 years old persons during 2009 
and 2017. In patients aged 25–74 years, 1713 (13.6%) died prehospital (PHD), 941 (7.5%) died within the first 
24 h after hospitalization (24hD) and 560 (4.5%) died within the 2nd and 28th day after the acute event (28dD); 
in patients aged 75–84 years the numbers were 1263 (26.6%), 749 (15.8%), and 329 (6.9%), respectively (Fig. 1 
and Table 1).
Table 1 shows the sociodemographic characteristics and the medical history for each of the four subgroups 
of the two age groups and time periods. Due to different data sources for fatal and non-fatal cases used in our 
registry, some information was not available as described in the method part. In addition, we observed higher 
missing values in PHD cases compared to 28-day survivors. In PHD cases, nicotine abuse was known in 23.6% of 
the 25–74 years old and in 10.5% of the 75–84 years old. Among 28-day survivors, actual smoking was reported 
by 36.6% of the 25–74 years old and by 6.5% of the older age-group. Angina pectoris and previous MI was more 
often seen in fatal compared to non-fatal cases. For example, in the 75–84 years old, previous MI was known in 
48.1% of PHD and 56.3% of 24hD cases versus 23.7% of 28dD and 24.6% of the 28-day survivors.
Table 2 provides additional characteristics on witness and place of death, autopsy and length of survival 
for fatal cases. The frequencies observed were similar in both age groups except for autopsy (e.g., ‘no autopsy 
performed’ in PHD: 95.2% of 25–74 years old versus 99.4% of 75–84 years old cases) and length of survival after 
the acute event. Despite differences in missing frequencies for the variable ‘time between pain and death’, we 
revealed a considerable number of patients dying within one hour after pain onset. In PHD and 24hD cases, the 
frequencies of cardiac death within 1 h after pain onset were 38.5% in 25–74 years old and 24.4% in 75–84 years 
old cases, and 18.3% in 25–74 years old and 12.3% in 75–84 years old cases, respectively (Table 2).
Determinants associated with prehospital death. Results of the multivariable logistic regression 
models are provided in Table 3. In both age groups increasing age, actual smoking or nicotine abuse, previous 
MI, angina pectoris and previous stroke were more likely and hypertension was less likely in cases with prehos-
pital death compared to 28-day survivors. For example, in the 25–74 years old we revealed an odds ratio (OR) 
of 4.53 (95% CI 3.84–5.34) for angina pectoris and an OR of 0.69 (95% CI 0.57–0.85) for hypertension. An asso-
ciation of living alone (OR 1.26, 95% CI 1.06–1.49) and diabetes (OR 1.20, 95% CI 1.03–1.41) with prehospital 
death was only found in cases aged 25–74 years. In cases aged 75–84 years, COPD (OR 2.20, 95%CI 1.69–2.85) 
was associated with prehospital death.
The sub-analyses including all short-term fatal cases (PHD and 24hD) revealed results similar to those in 
Table 3, with one exception; in 25–74 years old cases, the variable ‘living alone’ was not found to be associated 
with the combined outcome of prehospital and early in-hospital death (data shown in Supplementary Table 1).
Discussion
We performed an analysis of prehospital and early in-hospital CHD deaths and investigated patients’ charac-
teristics associated with prehospital death in comparison with at least 28-day survival based on data of 17,326 
participants from the epidemiological KORA MI registry in Augsburg, Germany. We found that 13.6% of the 
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Figure 1.  Study population (n = 17,326) from the KORA Myocardial infarction (MI) registry.
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Table 1.  Characteristics of the study population (n = 17,326) by age-group and the epidemiologic MONICA 
algorithm for the fatal coronary heart disease and non-fatal acute MI diagnosis. PHD pre-hospital deaths, 
24hD death within the first 24 h after hospitalization, 28dD death within 2nd and 28th day after acute event, 
28dS 28-day survivors, n.a. not available due to differences in data source and data collection regarding fatal 
and non-fatal cases, COPD chronic obstructive pulmonary disease.
25–74 years old cases between 2003–2017 
(n = 12,572) 75–84 years old cases between 2009–2017 (n = 4754)
Fatal (n = 2654) Non-fatal (n = 9918) Fatal (n = 2012) Non-fatal (n = 2742)
PHD 24hD 28dD 28dS PHD 24hD 28dD 28dS
Included cases, n 1713 941 560 9358 1263 749 329 2413
Socio-demographics
Mean (SD) age, y 64.7 (8.1) 66.1 (7.6) 65.6 (7.5) 61.0 (9.5) 80.1 (2.8) 79.7 (2.9) 79.9 (2.8) 79.1 (2.8)
Median (IQR) age, y 67 (10) 68 (9) 67 (10) 63 (15) 81 (5) 80 (5) 80 (4) 79 (4)
Women, n (%) 380 (22.2) 214 (22.7) 148 (26.4) 2259 (22.1) 516 (40.9) 283 (37.8) 141 (42.9) 1010 (41.9)
Nation, n (%)
German 1404 (82.0) 730 (77.6) 512 (91.4) 8372 (89.5) 1090 (86.3) 564 (75.3) 311 (94.5) 2288 (94.8)
Other 77 (4.5) 50 (5.3) 44 (7.9) 980 (10.5) 27 (2.1) 18 (2.4) 18 (5.5) 116 (4.8)
Missing information 232 (13.5) 161 (17.1) 4 (0.7) 6 (0.1) 146 (11.6) 167 (22.3) 0 9 (0.4)
Living alone, n (%)
Yes 309 (18.0) 54 (5.7) 44 (7.9) 1755 (18.8) 307 (24.3) 99 (13.2) 47 (14.3) 618 (25.6)
Missing information 556 (32.5) 436 (46.3) 166 (29.6) 465 (5.0) 176 (13.9) 274 (36.6) 77 (23.4) 156 (6.5)
Obesity, n (%)
Yes 329 (19.2) 112 (11.9) 82 (14.6) 2592 (27.7) 188 (14.9) 71 (9.5) 34 (10.3) 508 (21.1)
Missing information 613 (35.8) 368 (39.1) 304 (54.3) 375 (4.0) 186 (14.7) 201 (26.8) 152 (46.2) 139 (5.8)
Nicotine abuse, n (%)
Yes 405 (23.6) 196 (20.8) n.a n.a 132 (10.5) 96 (12.8) n.a n.a
Missing information 605 (35.3) 363 (38.6) n.a n.a 185 (14.7) 203 (27.1) n.a n.a
Smoking
Actual n.a n.a 148 (26.4) 3425 (36.6) n.a n.a 25 (7.6) 157 (6.5)
Former n.a n.a 118 (21.1) 2944 (31.5) n.a n.a 53 (16.1) 808 (33.5)
Never n.a n.a 47 (8.4) 2416 (25.8) n.a n.a 52 (15.8) 1122 (46.5)
Missing information n.a n.a 247 (44.1) 573 (6.1) n.a n.a 199 (60.5) 326 (13.5)
Medical history, n (%)
Hypertension
Yes 1185 (69.2) 601 (63.9) 413 (73.8) 7264 (77.6) 985 (78.0) 511 (68.2) 267 (81.2) 2172 (90.0)
Missing information 235 (13.7) 180 (19.1) 3 (0.5) 0 135 (10.7) 165 (22.0) 0 0
Diabetes mellitus
Yes 625 (36.5) 360 (38.3) 252 (45.0) 3015 (32.2) 505 (40.0) 272 (36.3) 145 (44.1) 992 (41.1)
Missing information 249 (14.5) 180 (19.1) 2 (0.4) 1 (0.01) 144 (11.4) 166 (22.2) 0 1 (0.04)
Dyslipidaemia
Yes 857 (50.0) 367 (39.0) 226 (40.4) 5894 (63.0) 641 (50.8) 306 (40.9) 145 (44.1) 1344 (55.7)
Missing information 293 (17.1) 205 (21.8) 4 (0.7) 3 (0.03) 173 (13.7) 194 (25.9) 0 0
Previous MI
Yes 716 (41.8) 433 (46.0) 148 (26.4) 1699 (18.2) 607 (48.1) 422 (56.3) 78 (23.7) 594 (24.6)
Missing information 233 (13.6) 146 (15.5) 0 4 (0.04) 159 (12.6) 110 (14.7) 0 0
Angina pectoris
Yes 728 (42.5) 309 (32.8) 109 (19.5) 1569 (16.8) 510 (40.4) 228 (30.4) 55 (16.7) 499 (20.7)
Missing information 442 (25.8) 311 (33.1) 25 (4.5) 46 (0.5) 291 (23.0) 298 (39.8) 7 (2.1) 11 (0.5)
Stroke
Yes 229 (13.4) 109 (11.6) 81 (14.5) 656 (7.0) 313 (24.8) 138 (18.4) 58 (17.6) 364 (15.1)
Missing information 298 (17.4) 206 (21.9) 85 (15.2) 270 (2.9) 167 (13.2) 181 (24.2) 26 (7.9) 67 (2.8)
Cancer
Yes 123 (7.2) 99 (10.5) n.a n.a 182 (14.4) 136 (18.2) n.a n.a
Missing information 633 (37.0) 373 (39.6) n.a n.a 245 (19.4) 219 (29.2) n.a n.a
COPD
Yes 239 (14.0) 112 (11.9) 48 (8.6) 323 (3.5) 195 (15.4) 99 (13.2) 36 (10.9) 221 (9.2)
Missing information 612 (35.7) 362 (38.5) 255 (45.5) 3798 (40.6) 179 (14.2) 184 (24.6) 1 (0.3) 4 (0.2)
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included cases aged 25–74 years and 26.6% of included cases aged 75–84 years died before reaching a hospital. 
In addition, 7.5% of the 25–74 years old and 15.8% of the 75–84 years old patients died within the first 24 h after 
hospitalization. Prehospital death after the acute event was associated with increasing age, nicotine abuse or 
actual smoking, previous MI, angina pectoris, previous stroke and absence of hypertension in both age groups. 
In the 25–74 years old cases, living alone, diabetes mellitus and absence of hyperlipidaemia were also found to 
be associated with prehospital death. In the elderly group where information on COPD was available during 
the total study period, persons with COPD, and non-obese persons more likely died before reaching a hospital.
Our findings of a high prehospital and early in-hospital case fatality are in concordance with prior  studies1,3,5. 
For example, Koukkunen et al.3 examined 30,561 suspected acute MIs in persons aged 75–99 years in Finland 
and found an age-standardized prehospital case fatality among persons aged 75–84 years of 25.5% in men and 
20.2% in women, that is similar to our prehospital case fatality of 26.6% among the 75–84 years old patients. 
Also, a nationwide Swedish study including 384,597 cases aged 35 to 84 years with a first major coronary event 
occurring between 1991 and 2006 found a high percentage of 28.9% out-of-hospital deaths and further 9.5% 
who died in the hospital or within 28 days after  hospitalization5.
The high frequencies of about 39% in the 25–74 years old and 24% in the 75–84 years old cases observed in 
our analysis regarding length of survival after pain onset of less than one hour indicates that sudden coronary 
death (SCD) might be the main cause of death in these patients. This assumption is encouraged by the small 
proportion of present physicians (5–6%) and the high frequency of 36% among prehospital fatal cases with no 
witness for testifying the out-of-hospital deaths. A prospective study in France estimated that 35% out-of-hospital 
sudden deaths were due to acute  MI16. The Finnish Genetic Study of Arrhythmic  Events17 found an even higher 
proportion of sudden deaths in relation to CHD. Vähätalo et al.17 reported that in 74.8% out of 5869 individuals 
with autopsy-verified SCD, the cause of sudden death was a coronary artery disease; however, in 1322 individuals 
(42.4%) with SCD a silent MI was detected although no prior diagnosis of a coronary artery disease was recorded. 
As systematic assessment of SCD is complicated, the yearly rate varied widely between 18.6 and 128 cases per 
100,000 inhabitants among different countries. In a German district in Lower Saxony with 190,000 inhabitants, 
the incidence of sudden cardiac death was found to be stable between 2002 and 2009, and was estimated to be 81 
cases per 100,000 inhabitants per  year7. As shown with our data, an epidemiological MI registry could provide 
regular data on SCD rate within a defined population of about 680,000 inhabitants.
Previously, it was reported, that 62% of young persons with SCD experienced angina pectoris before death 
and 46% had contacts with the health care system because of cardiac  symptoms18. We found that established 
Table 2.  Additional characteristics of the fatal cases (n = 4666). PHD pre-hospital deaths, 24hD deaths within 
the first 24 h after hospitalization, MI myocardial infarction, ICD-9 International Classification of Diseases, 9th 
revision.
25–74 years old fatal 
cases (n = 2654)
75–84 years old fatal 
cases (n = 2012)
PHD 24hD PHD 24hD
Included cases, n 1713 941 1263 749
Witness of death, n (%)
Physician 90 (5.3) 744 (79.1) 71 (5.6) 517 (69.0)
Other witness 829 (48.4) 106 (11.3) 597 (47.3) 120 (16.0)
No witness 612 (35.7) 23 (2.4) 459 (36.3) 36 (4.8)
Missing information 182 (10.6) 68 (7.2) 136 (10.8) 76 (10.2)
Autopsy, n (%)
Yes (definite MI, in case of ICD-9 = 410, 411 or 412) 54 (3.2) 55 (5.8) 6 (0.5) 12 (1.6)
Yes (possible MI, in case of ICD-9 = 413 or 414) 14 (0.8) 14 (1.5) 2 (0.2) 2 (0.3)
No autopsy performed 1631 (95.2) 849 (90.2) 1255 (99.4) 727 (97.1)
Missing information 14 (0.8) 23 (2.4) 0 8 (1.1)
Place of death, n (%)
At home, at work or on the road 1541 (90.0) 0 1138 (90.1) 0
At transport to hospital 12 (0.7) 0 2 (0.2) 0
At hospital admission 0 135 (14.4) n.a 67 (9.0)
At intensive care 0 515 (54.7) n.a 298 (39.8)
At hospital, rehabilitation or hospice care 60 (3.5) 291 (30.9) 83 (6.6) 384 (51.3)
Others or insufficient data 100 (5.8) 0 40 (3.2) 0
Time between pain and death, n (%)
1 h or less 660 (38.5) 172 (18.3) 308 (24.4) 92 (12.3)
1–24 h 206 (12.0) 250 (26.6) 128 (10.1) 147 (19.6)
Mostly likely <  = 24 h 196 (11.4) 51 (5.4) 154 (12.2) 55 (7.3)
 > 24 h 80 (4.7) 199 (21.2) 91 (7.2) 178 (23.8)
Insufficient data 571 (33.3) 269 (28.6) 582 (46.1) 277 (37.0)
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risk factors of MI such as increasing age, angina pectoris, previous MI, previous stroke, smoking and diabetes 
mellitus were more likely in prehospital fatal cases compared to 28-day survivors. However, we observed lower 
rates of hypertension in fatal cases, possible due to underdiagnosis or missing information. In accordance with a 
previous  study5, we found that hypertension was inversely associated with prehospital death in both age groups. 
This may be a result of underdiagnosed hypertension as mentioned above as well as potential treatment with 
antihypertensive drugs and therefore better control of blood pressure in patients with known hypertension. Drug 
prescribing could also be one reason why cases aged 25–74 years who had known dyslipidaemia were less likely 
to die out-of-hospital. From modelling studies in CHD, it was demonstrated that primary prevention and control 
of risk factors are more important for a decrease in case fatality than  interventions5. Importantly, Dudas et al.5 
found an increasing temporal trend during 1991 to 2006 in out-of-hospital death with each successive calendar 
year, in cases with a first major coronary event.
In accordance with prior studies, our analyses showed that CV risk  factors10, living  alone11,12, but not  sex11, 
was associated with prehospital death. The significance of living alone disappeared in our sub-analyses within 
the 25–74 aged cases with prehospital or early in-hospital death, strengthening the impact of living alone on 
prehospital death. In addition, Sorlie et al.11 found in a sample of the US population between 1979 and 1989 a 
higher OR of out-of-hospital death due to CHD (OR 1.44, 95% CI 1.34–1.55) than in all cause of death (OR 1.60, 
95% CI 1.49–1.71) among persons living alone compared with a household size of more than one person. The 
authors discussed, that in case of a heart attack a person may be either unable to call for emergency help due to 
severe chest pain, or a spouse in the household may lead to earlier recognition of the cardiac warning symptoms 
and therefore may decide to notify emergency services rapidly. The observed absence of a medical witness or 
any other witness of death in our prehospital death cases supports the hypothesis that living alone is a relevant 
predictor of prehospital cardiac death, especially in persons below 75 years.
Our study adds to the hypothesis that obesity may be a protective factor for prehospital death in persons with 
acute coronary event 75 years and older. Importantly, when interpreting this result, one should keep in mind the 
limited information available on obesity especially regarding category or stages of obesity in fatal cases, where 
we received the information from the last treating physician. Therefore, misclassification cannot be ruled out. 
The findings could also be due to the known ‘obesity paradox’ observed in epidemiological studies defined as 
unexpected results that obese people seem to live longer than their normal- or underweight counterparts with 
CV  disease19. However, geriatric studies reported that obesity was positive related with survival and health status 
and the cut-off point of 25 kg/m2 for overweight—classified according to the WHO guidelines—may be overly 
restrictive in adults aged 64 years or  older19,20. Neeland et al.20 found even a U-shaped association between body 
mass index category and 3-year all-cause mortality after ST-segment elevation MI in patients aged >  = 65 years 
surviving to hospital discharge; where, patients with mild obesity (30–34.9 kg/m2) were at lowest risk. Finally, 
Table 3.  Factors associated with prehospital death compared to 28-day survival. MI myocardial infarction, 
COPD chronic obstructive pulmonary disease. a 1794 observations (n = 854 prehospital death cases; n = 940 
cases of 28-day survivors) were deleted due to missing values for the explanatory variables. COPD was 
not included in this model as information was not available up to 2008. b Note: 768 observations (n = 359 
prehospital death cases; n = 409 cases of 28-day survivors) were deleted due to missing values for the 
explanatory variables. c Obesity reported by last treating physicians (fatal cases) or defined as body mass 
index >  = 30 kg/m2 (non-fatal cases).
OR [95% CI] p Value
Model 1: Cases aged 25–74 years, 2003–2017 (n = 9277)a
Age (cont.) 1.05 [1.04–1.06]  < 0.0001
Living alone (yes vs. no) 1.26 [1.06–1.49] 0.01
Actual smoking/nicotine abuse (yes vs. no) 1.47 [1.24–1.75]  < 0.0001
Hypertension (yes vs. no) 0.69 [0.57–0.85] 0.0003
Diabetes mellitus (yes vs. no) 1.20 [1.03–1.41] 0.02
Dyslipidaemia (yes vs. no) 0.69 [0.59–0.82]  < 0.0001
Previous MI (yes vs. no) 1.87 [1.58–2.22]  < 0.0001
Angina pectoris (yes vs. no) 4.53 [3.84–5.34]  < 0.0001
Previous stroke (yes vs. no) 2.09 [1.68–2.61]  < 0.0001
Model 2: Cases aged 75–84 years, 2009–2017 (n = 2908)b
Age (cont.) 1.17 [1.14–1.21]  < 0.0001
Obesityc (yes vs. no) 0.80 [0.64–0.99] 0.04
Actual smoking/nicotine abuse (yes vs. no) 1.65 [1.21–2.23] 0.001
Hypertension (yes vs. no) 0.53 [0.40–0.71]  < 0.0001
Previous MI (yes vs. no) 2.28 [1.90–2.73]  < 0.0001
Angina pectoris (yes vs. no) 3.21 [2.68–3.86]  < 0.0001
Previous stroke (yes vs. no) 2.03 [1.64–2.51]  < 0.0001
COPD (yes vs. no) 2.20 [1.69–2.85]  < 0.0001
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as long as the protective effects of adiposity in aged people with CV disease is not known, our results need to be 
considered carefully and will need further confirmation.
Strength and limitations. Major strength of the present study is the setting of a population-based MI 
registry including cases of a clinically confirmed MI and validated coronary death consecutively registered in 
a defined study region including urban and rural areas. Furthermore, our research covers recent data up to 
2017, and included a number of additional characteristics of fatal cases such as length of survival, witness of 
death, medical history and nicotine abuse that were not incorporated in previous investigations. In addition, we 
were able to report data on sudden and non-sudden coronary deaths. From 2009 onwards, our MI registry was 
extended to elderly persons up to 84 years old; therefore, additional analyses for an increasing patient population 
with CHD could be performed.
Some limitations for interpretation of our findings should be noticed. Firstly, our data on fatal cases contains 
a considerable number of missing values that might have caused information bias due to potential underdiagno-
sis of medical conditions or risk factor presence, leading to possible over- or underestimation of reported odds 
ratios associated with prehospital death. Altogether, the high percentage of missing information on variables 
studied may have also caused selection bias through misclassification regarding our studied groups. Secondly, 
several changes in emergency medical services, care and treatment of acute MI occurred during our study period 
between 2003 to 2017 that possibly influenced survival after an acute coronary event. Subsequently, the composi-
tion of our defined groups might converge each other over time with the potential to attenuate the reported odds 
ratios. A further limitation is that information on life expectancies and health status as well as on biomarkers and 
genetic susceptibility of the individuals was not available and may has determined the underlying mechanism 
for early coronary death versus 28-day survival in our sample. Finally, the autopsy rate is very low in our data; 
therefore, misclassification cannot be ruled out and may have caused overestimation of CHD deaths.
Conclusions
In summary, we observed a high prehospital and early in-hospital case fatality after an acute coronary event 
and revealed that a considerable number of patients died of sudden cardiac death within one hour after pain 
onset. We found that established CV risk factors such as increasing age, angina pectoris, previous MI, previous 
stroke, smoking and diabetes mellitus were more likely in prehospital fatal cases compared to 28-day survivors. 
Moreover, the impact of living alone on out-of-hospital cardiac death seems particularly important in persons 
aged 25–74 years. To achieve a further decrease in CHD case fatality, primary prevention with control of risk 
factors as well as public awareness of heart attack symptoms are still major challenges for the society.
Data availability
The data will not be shared. Due to restrictions from Helmholtz Zentrum München, data are available upon 
request for any researcher based on a standard agreement on data provision within the KORA Research Platform.
Received: 13 April 2021; Accepted: 30 July 2021
References
 1. Dégano, I. R. et al. Acute myocardial infarction trends in Europe (AMITIE) study investigators. Twenty-five-year trends in myo-
cardial infarction attack and mortality rates, and case-fatality, in six European populations. Heart 101, 1413–1421 (2015).
 2. Tunstall-Pedoe, H. et al. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortal-
ity: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. 
Lancet 353, 1547–1557 (1999).
 3. Koukkunen, H. et al. FINAMI Study Group. Case fatality of acute coronary events is improving even among elderly patients; The 
FINAMI study 1995–2012. Ann. Med. 50, 35–45 (2018).
 4. Federal Health Reporting in Germany (Statistisches Bundesamt – Gesundheits-berichterstattung des Bundes). Data sources: 
MONICA/KORA Myocardial Infarction Registry Augsburg. https:// www. gbe- bund. de/ (2020).
 5. Dudas, K., Lappas, G., Stewart, S. & Rosengren, A. Trends in out-of-hospital deaths due to coronary heart disease in Sweden (1991 
to 2006). Circulation 123, 46–152 (2011).
 6. Ibanez, B. et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment 
elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of 
the European Society of Cardiology (ESC). Eur. Heart J. 39, 119–177 (2018).
 7. Martens, E. et al. Incidence of sudden cardiac death in Germany: Results from an emergency medical service registry in lower 
saxony. Europace 16, 1752–1758 (2014).
 8. Kuch, B. et al. Are there options to prevent early occurring deaths in acute myocardial infarction: Prospective evaluation of All 
<24 H in-hospital deaths, 2004–2006–the MONICA/KORA Augsburg infarction registry. Cardiology 116, 237–244 (2010).
 9. Tundstall-Pedoe, H. The world health organization MONICA project (monitoring trends and determinants in cardiovascular 
disease): A major international collaboration WHO MONICA project principal investigators. J. Clin. Epidemiol. 41, 105–114 
(1988).
 10. Mannsverk, J. et al. Trends in modifiable risk factors are associated with declining incidence of hospitalized and nonhospitalized 
acute coronary heart disease in a population. Circulation 133, 74–81 (2016).
 11. Sorlie, P. D., Coady, S., Lin, C. & Arias, E. Factors associated with out-of-hospital coronary heart disease death: The national 
longitudinal mortality study. Ann. Epidemiol. 14, 447–452 (2004).
 12. Lammintausta, A. et al. Prognosis of acute coronary events is worse in patients living alone: The FINAMI myocardial infarction 
register. Eur. J. Prev. Cardiol. 21, 989–996 (2014).
 13. Löwel, H., Lewis, M., Hörmann, A. & Keil, U. Case finding, data quality aspects and comparability of myocardial infarction registers: 
Results of a south German register study. J. Clin. Epidemiol. 44, 249–260 (1991).
 14. Meisinger, C., Hörmann, A., Heier, M., Kuch, B. & Löwel, H. Admission blood glucose and adverse outcomes in non-diabetic 
patients with myocardial infarction in the reperfusion era. Int. J. Cardiol. 113, 229–235 (2006).
9
Vol.:(0123456789)
Scientific Reports |        (2021) 11:17134  | https://doi.org/10.1038/s41598-021-96575-2
www.nature.com/scientificreports/
 15. Alpert, J. S., Thygesen, K., Antman, E. & Bassand, J. P. Myocardial infarction redefined—a consensus document of the Joint Euro-
pean Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J. Am. Coll. 
Cardiol. 36, 959–969 (2000).
 16. Adnet, F. et al. Incidence of acute myocardial infarction resulting in sudden death outside the hospital. Emerg. Med. J. 28, 884–886 
(2011).
 17. Vähätalo, J. H. et al. Association of silent myocardial infarction and sudden cardiac death. JAMA Cardiol. 4, 796–802 (2019).
 18. Jabbari, R. et al. Cardiac symptoms before sudden cardiac death caused by coronary artery disease: A nationwide study among 
young Danish people. Heart 99, 938–943 (2013).
 19. Osher, E. & Stern, N. Obesity in elderly subjects: In Sheep’s clothing perhaps, but still a wolf. Diabetes Care 32(2), 398–402 (2009).
 20. Neeland, I. J. et al. The obesity paradox, extreme obesity, and long-term outcomes in older adults with ST-segment elevation 
myocardial infarction: Results from the NCDR. Eur. Heart J. Qual. Care Clin. Outcomes 3, 183–191 (2017).
Acknowledgements
The KORA research platform and the MONICA Augsburg studies were initiated and financed by the Helmholtz 
Zentrum München, German Research Center for Environmental Health, which is funded by the German Federal 
Ministry of Education, Science, Research and Technology and by the State of Bavaria. Since the year 2000, the 
collection of MI data has been co-financed by the German Federal Ministry of Health to provide population-
based MI morbidity data for the official German Health Report (see www. gbe- bund. de). Steering partners of 
the MONICA/KORA Infarction Registry, Augsburg, include the KORA research platform, Helmholtz Zentrum 
München and the Department of Internal Medicine I, Cardiology, University Hospital of Augsburg. We thank 
all members of the Helmholtz Zentrum München, Independent Research Group Clinical Epidemiology, and the 
field staff in Augsburg who were involved in the planning and conduct of the study. We wish to thank the local 
health departments, the office-based physicians and the clinicians of the hospitals within the study area for their 
support. Finally, we express our appreciation to all registered participants.
Author contributions
U.A. and C.M. conceived the study. U.A. performed the statistical analyses and drafted the manuscript. C.M., 
M.H., C.T., and J.L. contributed to data acquisition and interpretation of data. C.M., M.H., C.T., and J.L. criti-
cally revised the manuscript for important intellectual content. All authors approved the final version of the 
manuscript and agreed to be accountable for all aspects of the work.
Funding
Open Access funding enabled and organized by Projekt DEAL. This research did not receive any specific grant 
from funding agencies in the public, commercial, or not-for-profit sectors.
Competing interests 
The authors declare no competing interests.
Additional information
Supplementary Information The online version contains supplementary material available at https:// doi. org/ 
10. 1038/ s41598- 021- 96575-2.
Correspondence and requests for materials should be addressed to U.A.
Reprints and permissions information is available at www.nature.com/reprints.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access  This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the 
Creative Commons licence, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons licence and your intended use is not 
permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from 
the copyright holder. To view a copy of this licence, visit http:// creat iveco mmons. org/ licen ses/ by/4. 0/.
© The Author(s) 2021
